Universal Biosensors Inc (UBI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Universal Biosensors Inc (UBI) has a cash flow conversion efficiency ratio of -0.301x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.13 Million ≈ $-1.51 Million USD) by net assets (AU$7.08 Million ≈ $5.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Universal Biosensors Inc to measure how much of total assets are equity-financed.
Universal Biosensors Inc - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Universal Biosensors Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Universal Biosensors Inc (UBI) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Universal Biosensors Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Universal Biosensors Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Metalore Resources Ltd
V:MET
|
0.024x |
|
Innovotech Inc
V:IOT
|
0.016x |
|
MacDonald Mines Exploration Ltd
V:BMK
|
-0.004x |
|
Nexera Technologies Ltd.
NASDAQ:NEXR
|
-0.306x |
|
Colabor Group Inc.
TO:GCL
|
0.101x |
|
Timah Resources Ltd
AU:TML
|
0.007x |
|
Enlitic Inc
AU:ENL
|
-0.698x |
|
Cosmo Metals Ltd
AU:CMO
|
-0.035x |
Annual Cash Flow Conversion Efficiency for Universal Biosensors Inc (2002–2024)
The table below shows the annual cash flow conversion efficiency of Universal Biosensors Inc from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Universal Biosensors Inc market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$17.37 Million ≈ $12.29 Million |
AU$-12.30 Million ≈ $-8.70 Million |
-0.708x | +5.51% |
| 2023-12-31 | AU$19.51 Million ≈ $13.80 Million |
AU$-14.62 Million ≈ $-10.34 Million |
-0.749x | -32.99% |
| 2022-12-31 | AU$26.09 Million ≈ $18.46 Million |
AU$-14.70 Million ≈ $-10.40 Million |
-0.563x | -57.19% |
| 2021-12-31 | AU$27.61 Million ≈ $19.53 Million |
AU$-9.90 Million ≈ $-7.00 Million |
-0.358x | -64.20% |
| 2020-12-31 | AU$37.98 Million ≈ $26.87 Million |
AU$-8.29 Million ≈ $-5.87 Million |
-0.218x | -129.81% |
| 2019-12-31 | AU$45.39 Million ≈ $32.12 Million |
AU$33.24 Million ≈ $23.52 Million |
0.732x | +2003.00% |
| 2018-12-31 | AU$50.67 Million ≈ $35.85 Million |
AU$1.76 Million ≈ $1.25 Million |
0.035x | -94.88% |
| 2017-12-31 | AU$12.77 Million ≈ $9.04 Million |
AU$8.69 Million ≈ $6.15 Million |
0.681x | +27.96% |
| 2016-12-31 | AU$13.25 Million ≈ $9.38 Million |
AU$7.05 Million ≈ $4.99 Million |
0.532x | +285.32% |
| 2015-12-31 | AU$13.26 Million ≈ $9.38 Million |
AU$1.83 Million ≈ $1.29 Million |
0.138x | +150.33% |
| 2014-12-31 | AU$19.74 Million ≈ $13.97 Million |
AU$-5.41 Million ≈ $-3.83 Million |
-0.274x | +51.04% |
| 2013-12-31 | AU$29.68 Million ≈ $21.00 Million |
AU$-16.63 Million ≈ $-11.77 Million |
-0.560x | -568.20% |
| 2012-12-31 | AU$39.37 Million ≈ $27.86 Million |
AU$-3.30 Million ≈ $-2.34 Million |
-0.084x | +58.99% |
| 2011-12-31 | AU$35.02 Million ≈ $24.78 Million |
AU$-7.16 Million ≈ $-5.07 Million |
-0.204x | -50.48% |
| 2010-12-31 | AU$47.22 Million ≈ $33.41 Million |
AU$-6.41 Million ≈ $-4.54 Million |
-0.136x | -218.81% |
| 2009-12-31 | AU$51.31 Million ≈ $36.31 Million |
AU$5.87 Million ≈ $4.15 Million |
0.114x | +177.99% |
| 2008-12-31 | AU$48.70 Million ≈ $34.46 Million |
AU$-7.14 Million ≈ $-5.05 Million |
-0.147x | +5.45% |
| 2007-12-31 | AU$60.07 Million ≈ $42.51 Million |
AU$-9.31 Million ≈ $-6.59 Million |
-0.155x | -146.03% |
| 2006-12-31 | AU$37.05 Million ≈ $26.21 Million |
AU$-2.33 Million ≈ $-1.65 Million |
-0.063x | -209.68% |
| 2005-12-31 | AU$3.93 Million ≈ $2.78 Million |
AU$226.00K ≈ $159.91K |
0.057x | +11.37% |
| 2004-12-31 | AU$3.97 Million ≈ $2.81 Million |
AU$205.00K ≈ $145.05K |
0.052x | -79.48% |
| 2002-12-31 | AU$1.36 Million ≈ $962.29K |
AU$342.00K ≈ $241.99K |
0.251x | -- |
About Universal Biosensors Inc
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of… Read more